BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Robiolo B, La Torre J, Duffy S, Leon E, Seki C, Torres A, Mattion N. Quantitative single serum-dilution liquid phase competitive blocking ELISA for the assessment of herd immunity and expected protection against foot-and-mouth disease virus in vaccinated cattle. J Virol Methods. 2010;166:21-27. [PMID: 20170683 DOI: 10.1016/j.jviromet.2010.02.011] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
Number Citing Articles
1 Sharma GK, Mahajan S, Matura R, Subramaniam S, Mohapatra JK, Pattnaik B. Quantitative single dilution liquid phase blocking ELISA for sero-monitoring of foot-and-mouth disease in India. Biologicals 2015;43:158-64. [DOI: 10.1016/j.biologicals.2015.03.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
2 Sharma GK, Mahajan S, Matura R, Subramaniam S, Ranjan R, Biswal J, Rout M, Mohapatra JK, Dash BB, Sanyal A, Pattnaik B. Diagnostic assays developed for the control of foot-and-mouth disease in India. World J Virol 2015;4:295-302. [PMID: 26279990 DOI: 10.5501/wjv.v4.i3.295] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
3 Puentes R, De Brun L, Algorta A, Da Silva V, Mansilla F, Sacco G, Llambí S, Capozzo AV. Evaluation of serological response to foot-and-mouth disease vaccination in BLV infected cows. BMC Vet Res 2016;12:119. [PMID: 27329153 DOI: 10.1186/s12917-016-0749-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
4 Capozzo AV, Wilda M, Bucafusco D, de los Ángeles Lavoria M, Franco-mahecha OL, Mansilla FC, Pérez-filgueira DM, Grigera PR. Vesicular Stomatitis Virus glycoprotein G carrying a tandem dimer of Foot and Mouth Disease Virus antigenic site A can be used as DNA and peptide vaccine for cattle. Antiviral Research 2011;92:219-27. [DOI: 10.1016/j.antiviral.2011.08.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
5 Knight-Jones TJ, Gubbins S, Bulut AN, Stärk KD, Pfeiffer DU, Sumption KJ, Paton DJ. Mass vaccination, immunity and coverage: modelling population protection against foot-and-mouth disease in Turkish cattle. Sci Rep 2016;6:22121. [PMID: 26916556 DOI: 10.1038/srep22121] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 3.4] [Reference Citation Analysis]
6 Wong CL, Yong CY, Ong HK, Ho KL, Tan WS. Advances in the Diagnosis of Foot-and-Mouth Disease. Front Vet Sci 2020;7:477. [PMID: 32974392 DOI: 10.3389/fvets.2020.00477] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
7 Sharma GK, Mahajan S, Matura R, Biswal JK, Ranjan R, Subramaniam S, Misri J, Bambal RG, Pattnaik B. Herd Immunity Against Foot-and-Mouth Disease Under Different Vaccination Practices in India. Transbound Emerg Dis 2017;64:1133-47. [DOI: 10.1111/tbed.12478] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
8 Asfor AS, Howe N, Grazioli S, Berryman S, Parekh K, Wilsden G, Ludi A, King DP, Parida S, Brocchi E, Tuthill TJ. Detection of Bovine Antibodies against a Conserved Capsid Epitope as the Basis of a Novel Universal Serological Test for Foot-and-Mouth Disease. J Clin Microbiol 2020;58:e01527-19. [PMID: 32188689 DOI: 10.1128/JCM.01527-19] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
9 Knight-Jones TJ, Edmond K, Gubbins S, Paton DJ. Veterinary and human vaccine evaluation methods. Proc Biol Sci 2014;281:20132839. [PMID: 24741009 DOI: 10.1098/rspb.2013.2839] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 4.7] [Reference Citation Analysis]
10 Willems T, Lefebvre DJ, Neyts J, De Clercq K. Diagnostic performance and application of two commercial cell viability assays in foot-and-mouth disease research. J Virol Methods 2011;173:108-14. [PMID: 21295609 DOI: 10.1016/j.jviromet.2011.01.015] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
11 Willems T, Lefebvre DJ, Goris N, Diev VI, Kremenchugskaya SR, Paul G, Haas B, De Clercq K. Characteristics of serology-based vaccine potency models for foot-and-mouth disease virus. Vaccine 2012;30:5849-55. [DOI: 10.1016/j.vaccine.2012.07.015] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]